Exercising in the COVID-19 era: implications in non-alcoholic fatty liver disease (NAFLD)
COVID-19 is a major public health pandemic. Risk factors for severe infection and poorer outcomes include cardiovascular disease, obesity, type 2 diabetes mellitus and non-alcoholic fatty liver disease (NAFLD). Lifestyle interventions, including diet and physical activity modifications, are the curr...
Main Authors: | Suzanne Norris, Philip O'Gorman |
---|---|
Format: | Article |
Language: | English |
Published: |
BMJ Publishing Group
2021-09-01
|
Series: | BMJ Open Gastroenterology |
Online Access: | https://bmjopengastro.bmj.com/content/8/1/e000568.full |
Similar Items
-
Non-Alcoholic Fatty Liver Disease (NAFLD) in Obesity
by: Rushad Patell, et al.
Published: (2014-01-01) -
The role of exercise on non-alcoholic fatty liver disease (NAFLD) systemic and mitochondrial-related mechanisms
by: Inês Oliveira Gonçalves
Published: (2019) -
The role of exercise on non-alcoholic fatty liver disease (NAFLD) systemic and mitochondrial-related mechanisms
by: Inês Gonçalves
Published: (2014) -
Nutritional Management in Non-Alcoholic Fatty Liver Disease (NAFLD)
by: Sepideh Mahboobi, et al.
Published: (2015-07-01) -
Effect of shikonin on non-alcoholic fatty liver disease (NAFLD) cells
by: Yu-Wen Chi, et al.
Published: (2017)